Seongnam-si, South Korea

Nam Chul Jung

This inventor holds 1 USPTO granted patent. Top assignee: Cha University Industry-Academic Cooperation Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nam Chul Jung. Retrieved from https://idiyas.com/inventor/nam-chul-jung-rqiu2d95

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nam Chul Jung: Innovator in Dendritic Cell Research

Introduction

Nam Chul Jung is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of immunology, particularly in enhancing the migration ability of dendritic cells. His innovative work has implications for the prevention and treatment of immune-related diseases.

Latest Patents

Nam Chul Jung holds a patent titled "Method for increasing dendritic cell migration ability, and use thereof." This patent discloses a method that can increase the migration ability of mature dendritic cells. It also enhances the induction of inflammatory cytokine production, T lymphocyte proliferation, and T lymphocyte polarization. The applications of this method are crucial for addressing various immune-related conditions.

Career Highlights

Nam Chul Jung is affiliated with the Cha University Industry-Academic Cooperation Foundation. His work at this institution has allowed him to focus on groundbreaking research that bridges the gap between academia and industry. His dedication to advancing scientific knowledge is evident in his innovative approaches to immunotherapy.

Collaborations

Nam Chul Jung collaborates with esteemed colleagues, including Dae Seog Lim and Soo-Yeoun Park. These partnerships enhance the research environment and foster the development of new ideas and methodologies in the field of immunology.

Conclusion

Nam Chul Jung is a key figure in dendritic cell research, with a patent that holds promise for treating immune-related diseases. His work exemplifies the importance of innovation in the medical field, and his contributions will likely have a lasting impact on immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…